Baxter International | BAX - أصول متداولة





أصول متداولة تغيير تاريخ
Abbott USD 25.51B 488M 2026-03
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 357.52M 566K 2026-03
AtriCure USD 313.69M 8.82M 2026-03
Avanos Medical USD 325M 30.4M 2026-03
Baxter International USD 6.85B 25M 2026-03
Becton, Dickinson and Co. USD 8.01B 1.18B 2026-03
Boston Scientific USD 8.68B 110M 2026-03
Cooper Companies USD 2.13B 27.4M 2025-12
Dexcom USD 4.33B 298.4M 2026-03
Edwards Lifesciences USD 6.23B 510.2M 2026-03
Fresenius EUR 11.03B 1.03B 2025-12
Globus Medical USD 2.2B 72.51M 2026-03
Halozyme Therapeutics USD 1B 177.83M 2026-03
ICU Medical USD 1.21B 22.69M 2026-03
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.71B 204.5M 2026-03
Integra LifeSciences USD 1.17B 12.47M 2026-03
Intuitive Surgical USD 11.52B 881.5M 2026-03
J&J USD 59.17B 3.55B 2026-03
Laboratory Of America USD 4.56B 538.3M 2026-03
Masimo USD 870.5M 55.5M 2026-03
Medtronic USD 24.07B 75M 2025-12
Merit Medical Systems USD 1.1B 61.62M 2026-03
Quest Diagnostics USD 2.57B 188M 2026-03
Smith & Nephew USD 4.63B 169M 2025-12
Stryker USD 13.34B 1.42B 2026-03
Tandem Diabetes Care USD 887.1M 268.96M 2026-03
Teleflex USD 1.86B 78.67M 2026-03
Terumo JPY 861.04B 45.48B 2026-03
Zimmer Biomet Holdings USD 4.96B 157.4M 2026-03